Publication | Closed Access
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
119
Citations
31
References
2020
Year
Esketamine may carry a clear potential for serious AEs, which deserves urgent clarification by means of further prospective studies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1